The principle of complementarity: Chemical versus biological space

Current Opinion in Chemical Biology

Volumn 9, Issue 3, 2005, Pages 296-303

  Haggarty, Stephen J ^a  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ACTIVITY; BIOLOGY; CALCULATION; CHEMICAL STRUCTURE; CHEMISTRY; GENOMICS; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; PROTEIN BINDING; PROTEOMICS; REVIEW; SYNTHESIS;

COMBINATORIAL CHEMISTRY TECHNIQUES; DATABASES, FACTUAL; DRUG DESIGN; GENOMICS; MODELS, BIOLOGICAL; MODELS, CHEMICAL;

EID: 20444378945     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2005.04.006     Document Type: Review

References (56)

1. F. Darvas, G. Dorman, P. Krajcsi, L.G. Puskas, Z. Kovari, Z. Lorincz, and L. Urge Recent advances in chemical genomics Curr Med Chem 11 2004 3119 3145
2. B.K. Wagner, S.J. Haggarty, and P.A. Clemons Chemical genomics: probing protein function using small molecules Am J Pharmacogenomics 4 2004 313 320
3. F.R. Salemme Chemical genomics as an emerging paradigm for postgenomic drug discovery Pharmacogenomics 4 2003 257 267 Describes the need for integrated quantitative affinity-based screens, computer-directed combinatorial chemistry, and structure-based drug design in chemical genomics.
4. S.L. Schreiber The small-molecule approach to biology: chemical genetics and diversity-oriented organic synthesis make possible the systematic exploration of biology Chem Eng News 81 2003 51 61
5. N.P. Savchuk, K.V. Balakin, and S.E. Tkachenko Exploring the chemogenomic knowledge space with annotated chemical libraries Curr Opin Chem Biol 8 2004 412 417 A review of the concept of annotated chemical libraries for the computational design of target-directed combinatorial libraries and chemical genomic screening.
6. C.P. Austin, L.S. Brady, T.R. Insel, and F.S. Collins NIH molecular libraries initiative Science 306 2004 1138 1139
7. C.M. Dobson Chemical space and biology Nature 432 2004 824 828 An overview of chemical space with a discussion of the regions of chemical space that may give rise to the discovery of new bioactive molecules.
8. B.R. Stockwell Exploring biology with small organic molecules Nature 432 2004 846 854 Describes the concept of biological-activity space and the analogy of mapping chemical space with mapping of the stars. Provides an overview of phenotypic assays.
9. C. Lipinski, and A. Hopkins Navigating chemical space for biology and medicine Nature 432 2004 855 861 The authors review strategies for identifying small molecules that modulate biological targets, and discuss the difference between strategies for understanding biology versus drug discovery.
10. D.K. Agrafiotis Multiobjective optimization of combinatorial libraries Mol Divers 5 2002 209 230 The authors comprehensively review recent advances in the development of computational tools for analyzing chemical space.
11. D.K. Agrafiotis, V.S. Lobanov, and F.R. Salemme Combinatorial informatics in the post-genomics ERA Nat Rev Drug Discov 1 2002 337 346 An excellent overview of cheminformatics and data mining in the design of combinatorial libraries, compound selection and experimental design.
12. T.I. Oprea, and J. Gottfries Chemography: the art of navigating in chemical space J Comb Chem 3 2001 157 166
13. T.I. Oprea Chemical space navigation in lead discovery Curr Opin Chem Biol 6 2002 384 389 The authors review approaches to measure similarity in chemical property space and methods for navigation using a 'chemical global positioning system' (ChemGPS) consisting of coordinates derived from principal component analysis of the molecular descriptors of a predefined set of 'satellite' and 'core' structures.
14. S.J. Haggarty, P.A. Clemons, J.C. Wong, and S.L. Schreiber Mapping chemical space using molecular descriptors and chemical genetics: deacetylase inhibitors Comb Chem High Throughput Screen 7 2004 669 676 The authors used principal component analysis and three-dimensional visualizations to analyze a molecular descriptor space to determine the contribution of different diversity elements. Phenotypic descriptors derived from measurements of small-molecule activities in an array of cell-based assays were then used to filter the space and reveal subspaces with different selectivity and potencies.
15. Z.E. Perlman, M.D. Slack, Y. Feng, T.J. Mitchison, L.F. Wu, and S.J. Altschuler Multidimensional drug profiling by automated microscopy Science 306 2004 1194 1198 The authors profiled the dose-dependent phenotypic effects of small molecules in cultured human cells using automated microscopy. By calculating a titration-invariant similarity score their method successfully categorized blinded drugs and suggested targets for drugs of uncertain mechanism.
16. S.J. Haggarty, K.M. Koeller, J.C. Wong, R.A. Butcher, and S.L. Schreiber Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays Chem Biol 10 2003 383 396
17. D.E. Root, S.P. Flaherty, B.P. Kelley, and B.R. Stockwell Biological mechanism profiling using an annotated compound library Chem Biol 10 2003 881 892
18. K.M. Comess, and M.E. Schurdak Affinity-based screening techniques for enhancing lead discovery Curr Opin Drug Discov Devel 7 2004 411 416 A summary of technologies available for affinity-based high-throughput screening.
19. S. Jager, L. Brand, and C. Eggeling New fluorescence techniques for high-throughput drug discovery Curr Pharm Biotechnol 4 2003 463 476 A summary of fluorescent-based technologies for high-throughput screening.
20. M.A. Cooper Optical biosensors in drug discovery Nat Rev Drug Discov 1 2002 515 528
21. Q. Xu, and K.S. Lam Protein and chemical microarrays - powerful tools for proteomics J Biomed Biotechnol 2003 2003 257 266
22. G.Y. Chen, M. Uttamchandani, R.Y. Lue, M.L. Lesaicherrea, and S.Q. Yao Array-based technologies and their applications in proteomics Curr Top Med Chem 3 2003 705 724
23. D. Barnes-Seeman, S.B. Park, A.N. Koehler, and S.L. Schreiber Expanding the functional group compatibility of small-molecule microarrays: discovery of novel calmodulin ligands Angew Chem Int Ed Engl 42 2003 2376 2379
24. A.N. Koehler, A.F. Shamji, and S.L. Schreiber Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis J Am Chem Soc 125 2003 8420 8421 An important example of using small-molecule microarrays to discover an inhibitor of a class of proteins previously refractory to most attempts to modulate their function.
25. M. Uttamchandani, D.P. Walsh, S.Q. Yao, and Y.T. Chang Small molecule microarrays: recent advances and applications Curr Opin Chem Biol 9 2005 4 13
26. J. LaBaer, and N. Ramachandran Protein microarrays as tools for functional proteomics Curr Opin Chem Biol 9 2005 14 19
27. J. Huang, H. Zhu, S.J. Haggarty, D.R. Spring, H. Hwang, F. Jin, M. Snyder, and S.L. Schreiber Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips Proc Natl Acad Sci USA 101 2004 16594 16599
28. Y. Ho, A. Gruhler, A. Heilbut, G.D. Bader, L. Moore, S.L. Adams, A. Millar, P. Taylor, K. Bennett, and K. Boutilier Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry Nature 415 2002 180 183
29. S.J. Haggarty, K.M. Koeller, J.C. Wong, C.M. Grozinger, and S.L. Schreiber Domain-selective small molecule inhibitor of HDAC6-mediated tubulin deacetylation Proc Natl Acad Sci USA 100 2003 4389 4394
30. T.R. Kau, F. Schroeder, S. Ramaswamy, C.L. Wojciechowski, J.J. Zhao, T.M. Roberts, J. Clardy, W.R. Sellers, and P.A. Silver A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells Cancer Cell 4 2003 463 476 An image-based screen was used to identify inhibitors of FOXO1a nuclear export was performed and identified several general export inhibitors targeting CRM1, as well as several compounds that inhibit PI3K/Akt signaling.
31. K.M. Koeller, S.J. Haggarty, B.D. Perkins, I. Leykin, J.C. Wong, M.C. Kao, and S.L. Schreiber Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation Chem Biol 10 2003 397 410 The concept of using chemical genetic modifier screens to partition chemical space is introduced using assays relevant to chromatin remodeling and cytoskeletal dynamics.
32. Y. Feng, S. Yu, T.K. Lasell, A.P. Jadhav, E. Macia, P. Chardin, P. Melancon, M. Roth, T. Mitchison, and T. Kirchhausen Exo1: a new chemical inhibitor of the exocytic pathway Proc Natl Acad Sci USA 100 2003 6469 6474
33. S. Ding, T.Y. Wu, A. Brinker, E.C. Peters, W. Hur, N.S. Gray, and P.G. Schultz Synthetic small molecules that control stem cell fate Proc Natl Acad Sci USA 100 2003 7632 7637 A pioneering example of screening for small molecules that modulate stem cell biology.
34. R.A. Butcher, and S.L. Schreiber A small molecule suppressor of FK506 that targets the mitochondria and modulates ionic balance in Saccharomyces cerevisiae Chem Biol 10 2003 521 531
35. B.L. Apostol, A. Kazantsev, S. Raffioni, K. Illes, J. Pallos, L. Bodai, N. Slepko, J.E. Bear, F.B. Gertler, and S. Hersch A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila Proc Natl Acad Sci USA 100 2003 5950 5955
36. S.J. Haggarty, K.M. Koeller, T.R. Kau, P.A. Silver, M. Roberge, and S.L. Schreiber Small molecule modulation of the human chromatid decatenation checkpoint Chem Biol 10 2003 1267 1279
37. T.J. Mitchison Small-molecule screening and profiling by using automated microscopy ChemBioChem 6 2005 33 39 A comprehensive review of the use of automated microscopy for discovering new biological probes.
38. J.C. Yarrow, Z.E. Perlman, N.J. Westwood, and T.J. Mitchison A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods BMC Biotechnol 4 2004 21
39. U.S. Eggert, A.A. Kiger, C. Richter, Z.E. Perlman, N. Perrimon, T.J. Mitchison, and C.M. Field Parallel chemical genetic and genome-wide RNAi screens identify cytokinesis inhibitors and targets PLoS Biol 2 2004 e379 This study provides an example of using parallel RNA interference and small molecule screening to identifying active small molecules and their target pathways.
40. K.L. Carey, N.J. Westwood, T.J. Mitchison, and G.E. Ward A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii Proc Natl Acad Sci USA 101 2004 7433 7438
41. Y.K. Kim, M.A. Arai, T. Arai, J.O. Lamenzo, E.F. Dean III, N. Patterson, P.A. Clemons, and S.L. Schreiber Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space J Am Chem Soc 126 2004 14740 14745 Multidimensional cell-based screening was used to quantitatively assess the contribution of stereochemical and skeletal diversity to the global activity patterns of a set of small molecules. Conformational restriction was found to increase the specificity of responses, whereas the role of stereochemistry depended upon the context of the stereocenter.
42. V. Mastyugin, E. McWhinnie, M. Labow, and F. Buxton A quantitative high-throughput endothelial cell migration assay J Biomol Screen 9 2004 712 718
43. J.X. Brown, P.D. Buckett, and M. Wessling-Resnick Identification of small molecule inhibitors that distinguish between non-transferrin bound iron uptake and transferrin-mediated iron transport Chem Biol 11 2004 407 416
44. R.T. Peterson, S.Y. Shaw, T.A. Peterson, D.J. Milan, T.P. Zhong, S.L. Schreiber, C.A. MacRae, and M.C. Fishman Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation Nat Biotechnol 22 2004 595 599 The authors used a whole-organism screen to discover a class of compounds that suppress an aortic coarctation phenotype in zebrafish, which function during the specification and migration of angioblasts through a mechanism involving vascular endothelial growth factor.
45. D.J. Diller, and D.W. Hobbs Deriving knowledge through data mining high-throughput screening data J Med Chem 47 2004 6373 6383 Statistical models were used to analyze high-throughput screening data to determine the effects of physical properties and substructures on the likelihood of compounds showing biological activity over a broad range of pharmaceutically relevant targets.
46. J. Clardy, and C. Walsh Lessons from natural molecules Nature 432 2004 829 837 Insightful comparisons of the structural properties of natural products and synthetic drugs and drug candidates.
47. S.J. Haggarty, P.A. Clemons, and S.L. Schreiber Chemical genomic profiling of biological networks using graph theory and combinations of small molecule perturbations J Am Chem Soc 125 2003 10543 10545
48. M.A. Koch, L.O. Wittenberg, S. Basu, D.A. Jeyaraj, E. Gourzoulidou, K. Reinecke, A. Odermatt, and H. Waldmann Compound library development guided by protein structure similarity clustering and natural product structure Proc Natl Acad Sci USA 101 2004 16721 16726 Using 'protein structure similarity clustering', a 147-member compound collection derived from the naturally occurring Cdc25A inhibitor dysidiolide yielded potent and selective inhibitors of the other members of a protein similarity cluster with a hit rate of 2-3%.
49. J.N. Weinstein, T.G. Myers, P.M. O'Connor, S.H. Friend, A.J. Fornace Jr., K.W. Kohn, T. Fojo, S.E. Bates, L.V. Rubinstein, and N.L. Anderson An information-intensive approach to the molecular pharmacology of cancer Science 275 1997 343 349
50. D.K. Agrafiotis, and H. Xu A geodesic framework for analyzing molecular similarities J Chem Inf Comput Sci 43 2003 475 484 An example of using non-linear dimensionality reduction to map chemical space based upon modeling the space as a manifold with local curvature.
51. A.B. Parsons, R. Geyer, T.R. Hughes, and C. Boone Yeast genomics and proteomics in drug discovery and target validation Prog Cell Cycle Res 5 2003 159 166
52. T. Hughes, B. Andrews, and C. Boone Old drugs, new tricks: using genetically sensitized yeast to reveal drug targets Cell 116 2004 5 7
53. S. Ghaemmaghami, W.K. Huh, K. Bower, R.W. Howson, A. Belle, N. Dephoure, E.K. O'Shea, and J.S. Weissman Global analysis of protein expression in yeast Nature 425 2003 737 741
54. X. Pan, D.S. Yuan, D. Xiang, X. Wang, S. Sookhai-Mahadeo, J.S. Bader, P. Hieter, F. Spencer, and J.D. Boeke A robust toolkit for functional profiling of the yeast genome Mol Cell 16 2004 487 496 The authors describe a microarray-based technique, referred to as dSLAM (diploid-based synthetic lethality analysis on microarrays), to probe genome-wide gene-chemical and gene-gene interactions, which is more robust than existing methods for profiling small molecules against the yeast genome.
55. P.Y. Lum, C.D. Armour, S.B. Stepaniants, G. Cavet, M.K. Wolf, J.S. Butler, J.C. Hinshaw, P. Garnier, G.D. Prestwich, and A. Leonardson Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes Cell 116 2004 121 137 Using barcoded yeast heterozygote strains and the principle of haploinsufficiency the authors profiled 78 compounds and revealed several novel targets.
56. G. Giaever, P. Flaherty, J. Kumm, M. Proctor, C. Nislow, D.F. Jaramillo, A.M. Chu, M.I. Jordan, A.P. Arkin, and R.W. Davis Chemogenomic profiling: identifying the functional interactions of small molecules in yeast Proc Natl Acad Sci USA 101 2004 793 798